INVITATION TO TELEPHONE CONFERENCE Elekta will publish its three months interim report 2008/09 on Thursday September 18 at around 13.00 CET and a telephone conference will be held the following day, Friday September 19, at 10.00 CET. Tomas Puusepp, President and CEO, and Håkan Bergström, CFO, will comment the first quarter results and answer questions. To take part in the conference call, please dial in about five minutes in advance. You will be placed in a so-called waiting room until the chairman has declared the meeting opened. Call-in numbers for teleconference, September 19 at 10.00 CET UK: +44 (0)20 7162 0025 US: +1 334 323 6201 Norway: +47 2156 312 0 France: +33 (0)1 7099 3208 Germany: +49 (0)695 8999 0507 Netherlands: +31 (0)20 7965 008 Sweden: +46 (0)8 5052 0110 Denmark: +45 3271 4607 Switzerland (Geneva): +41 (0)2 2592 7007 Switzerland (Zurich): +41 (0)434 5692 61 Please note that for local connect dial-in numbers it may be required to dial the area code to enter the conference. The teleconference will also be broadcasted over the Internet (audio only). Please visit www.elekta.com - Investors, or use the direct link: http://wcc.webeventservices.com/view/wl/r.htm?e=117926&s=1&k=B4B7CF61FBA2C2945A1 14DF02EDF6264&cb=genesys The telephone conference will be available afterwards on instant replay for seven days. Please dial U.K. +44 (0)207 031 40 64, Sweden +46 (0) 8 505 203 33, US +1 954 334 03 42 and use access code 807583. For further information, please contact: Lena Schattauer, Investor Relations, Elekta AB Tel: +46 8 587 257 22, +46 70 595 51 00, e-mail: lena.schattauer@elekta.com About Elekta Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state-of-the-art tools to fight serious disease. Elekta provides advanced clinical solutions, comprehensive management and information systems, as well as services for improved cancer care and management of brain disorders. Elekta's systems and solutions are used in over 5,000 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy and radiosurgery, and the MOSAIQ® suite of software for image enabled EMR and efficient management of clinical and patient data. With approximately 2,400 employees globally, the corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at www.elekta.com
INVITATION TO TELEPHONE CONFERENCE
| Source: Elekta AB
Attachments
